U.S. markets closed

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
245.50-2.46 (-0.99%)
At close: 4:00PM EST

245.50 0.00 (0.00%)
After hours: 4:27PM EST

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000

IndustryMedical Instruments & Supplies
Full Time Employees1,600

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph E. KianiFounder, CEO & Chairman3MN/A1965
Mr. Micah YoungExec. VP of Fin. & CFO713.37k782.13k1979
Mr. Bilal MuhsinChief Operating Officer892.51k2.57M1981
Dr. Steven J. BarkerChairman of Scientific Advisory Board, Chief Science Officer & Director190kN/A1945
Mr. Thomas Samuel McClenahanExec. VP, Gen. Counsel & Corp. Sec.718.05k1.39M1973
Mr. Anand SampathExec. VP of Operations & Clinical Research774.84k8.08M1966
Mr. J. Todd KoningSr. VP & Chief Accounting OfficerN/AN/A1972
Mr. Yongsam LeeExec. VP & Chief Information OfficerN/AN/A1965
Mr. Eli KammermanVP of Bus. Devel. & Investor RelationsN/AN/AN/A
Mr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsN/AN/A1964
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.

Corporate Governance

Masimo Corporation’s ISS Governance QualityScore as of November 1, 2019 is 5. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.